| Alejandro Saul Casillas, MD | |
|
275 Hospital Dr, Ukiah, CA 95482-4531 | |
| (707) 462-7900 | |
| (707) 462-7947 |
| Full Name | Alejandro Saul Casillas |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 16 Years |
| Location | 275 Hospital Dr, Ukiah, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376707919 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A114918 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital-santa Rosa | Santa rosa, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
Hovione is pleased to announce that its TwinCaps(R) inhaler licensees Daiichi Sankyo Co. Ltd. (Tokyo, Japan) and Biota Holdings Ltd (Victoria, Australia) have both announced successful Phase III trials for CS-8958, a new long-acting neuraminidase inhibitor for treatment of influenza (known as a prodrug of laninamivir).
"Two U.N. agencies on Monday presented a new tool to map health risks linked to climate change and extreme weather conditions, enabling authorities to give advance warnings and act to prevent 'climate-sensitive' diseases from spreading," Agence France-Presse reports.
Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal and metabolic diseases, today announced positive results from its 371 patient Phase 2b clinical trial evaluating tenapanor in patients with constipation-predominant irritable bowel syndrome (IBS-C).
The United States Food and Drug Administration (US FDA) yesterday – 14th of September 2017, permitted the marketing of an application developed for mobiles that would help in the treatment of substance use disorders (SUD).
Rutgers is one of seven institutions in the country selected by the National Institutes of Health to receive this year's BEST Award - a $2 million grant designed to expose many of the university's most promising biomedical sciences graduate trainees to career opportunities that go beyond the academic path that they have traditionally taken.
› Verified 9 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Hovione is pleased to announce that its TwinCaps(R) inhaler licensees Daiichi Sankyo Co. Ltd. (Tokyo, Japan) and Biota Holdings Ltd (Victoria, Australia) have both announced successful Phase III trials for CS-8958, a new long-acting neuraminidase inhibitor for treatment of influenza (known as a prodrug of laninamivir).
"Two U.N. agencies on Monday presented a new tool to map health risks linked to climate change and extreme weather conditions, enabling authorities to give advance warnings and act to prevent 'climate-sensitive' diseases from spreading," Agence France-Presse reports.
Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal and metabolic diseases, today announced positive results from its 371 patient Phase 2b clinical trial evaluating tenapanor in patients with constipation-predominant irritable bowel syndrome (IBS-C).
The United States Food and Drug Administration (US FDA) yesterday – 14th of September 2017, permitted the marketing of an application developed for mobiles that would help in the treatment of substance use disorders (SUD).
Rutgers is one of seven institutions in the country selected by the National Institutes of Health to receive this year's BEST Award - a $2 million grant designed to expose many of the university's most promising biomedical sciences graduate trainees to career opportunities that go beyond the academic path that they have traditionally taken.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alejandro Saul Casillas, MD 275 Hospital Dr, Ukiah, CA 95482-4531 Ph: (707) 462-7900 | Alejandro Saul Casillas, MD 275 Hospital Dr, Ukiah, CA 95482-4531 Ph: (707) 462-7900 |
News Archive
Hovione is pleased to announce that its TwinCaps(R) inhaler licensees Daiichi Sankyo Co. Ltd. (Tokyo, Japan) and Biota Holdings Ltd (Victoria, Australia) have both announced successful Phase III trials for CS-8958, a new long-acting neuraminidase inhibitor for treatment of influenza (known as a prodrug of laninamivir).
"Two U.N. agencies on Monday presented a new tool to map health risks linked to climate change and extreme weather conditions, enabling authorities to give advance warnings and act to prevent 'climate-sensitive' diseases from spreading," Agence France-Presse reports.
Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal and metabolic diseases, today announced positive results from its 371 patient Phase 2b clinical trial evaluating tenapanor in patients with constipation-predominant irritable bowel syndrome (IBS-C).
The United States Food and Drug Administration (US FDA) yesterday – 14th of September 2017, permitted the marketing of an application developed for mobiles that would help in the treatment of substance use disorders (SUD).
Rutgers is one of seven institutions in the country selected by the National Institutes of Health to receive this year's BEST Award - a $2 million grant designed to expose many of the university's most promising biomedical sciences graduate trainees to career opportunities that go beyond the academic path that they have traditionally taken.
› Verified 9 days ago
Dr. Ronald Landis Gester, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 275 Hospital Dr, Ukiah, CA 95482 Phone: 707-462-7900 Fax: 707-462-7947 | |
Charlie Edward Evans, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 Hospital Dr, Ukiah, CA 95482 Phone: 707-462-7900 Fax: 707-462-7947 | |
Dr. Jennifer Zernec, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 Hospital Dr, Ukiah, CA 95482 Phone: 707-463-7330 | |
Dr. Gary Fausone, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 Hospital Dr, Ukiah, CA 95482 Phone: 707-462-7900 Fax: 707-462-7947 | |
Debbie L Marks, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 Hospital Dr, Ukiah, CA 95482 Phone: 707-462-7900 Fax: 707-462-7947 | |
Dr. Jeffrey Alan Rapp, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 275 Hospital Dr, Ukiah, CA 95482 Phone: 707-467-5230 Fax: 707-467-5240 |